462 related articles for article (PubMed ID: 25294374)
1. Therapeutic radionuclides in nuclear medicine: current and future prospects.
Yeong CH; Cheng MH; Ng KH
J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic advances of nuclear medicine in oncology].
Valdés Olmos RA; Hoefnagel CA; Bais E; Boot H; Taal B; de Kraker J; Vote PA
Rev Esp Med Nucl; 2001 Dec; 20(7):547-57. PubMed ID: 11709141
[TBL] [Abstract][Full Text] [Related]
3. Is there life after technetium: what is the potential for developing new broad-based radionuclides?
Srivastava SC
Semin Nucl Med; 1996 Apr; 26(2):119-31. PubMed ID: 8723506
[TBL] [Abstract][Full Text] [Related]
4. Which radionuclides will nuclear oncology need tomorrow?
Barbet J; Chatal JF; Gauché F; Martino J
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):627-30. PubMed ID: 16741760
[No Abstract] [Full Text] [Related]
5. Nuclear medicine in the treatment of neuroendocrine tumours--problems and perspectives.
Grzela T; Bialoszewska A; Brawura-Biskupski-Samaha R
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):444-7. PubMed ID: 17136539
[No Abstract] [Full Text] [Related]
6. Targeted radionuclide therapy--an overview.
Dash A; Knapp FF; Pillai MR
Curr Radiopharm; 2013 Sep; 6(3):152-80. PubMed ID: 24059327
[TBL] [Abstract][Full Text] [Related]
7. Development of novel radionuclides for medical applications.
Qaim SM; Spahn I
J Labelled Comp Radiopharm; 2018 Mar; 61(3):126-140. PubMed ID: 29110328
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy in nuclear medicine--current status and future prospects.
Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
[TBL] [Abstract][Full Text] [Related]
9. Advances in cancer therapy with radiolabeled monoclonal antibodies.
Goldenberg DM; Sharkey RM
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):248-64. PubMed ID: 17043623
[TBL] [Abstract][Full Text] [Related]
10. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide therapy beyond radioiodine.
Gabriel M
Wien Med Wochenschr; 2012 Oct; 162(19-20):430-9. PubMed ID: 22815123
[TBL] [Abstract][Full Text] [Related]
12. Use of therapeutic radionuclides in medicine.
Early PJ; Landa ER
Health Phys; 1995 Nov; 69(5):677-94. PubMed ID: 7558861
[TBL] [Abstract][Full Text] [Related]
13. The bright future of radionuclides for cancer therapy.
Nijsen JF; Krijger GC; van Het Schip AD
Anticancer Agents Med Chem; 2007 May; 7(3):271-90. PubMed ID: 17504155
[TBL] [Abstract][Full Text] [Related]
14. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
15. Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside.
Van Laere C; Koole M; Deroose CM; de Voorde MV; Baete K; Cocolios TE; Duchemin C; Ooms M; Cleeren F
Theranostics; 2024; 14(4):1720-1743. PubMed ID: 38389843
[TBL] [Abstract][Full Text] [Related]
16. Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects.
Bhardwaj R; van der Meer A; Das SK; de Bruin M; Gascon J; Wolterbeek HT; Denkova AG; Serra-Crespo P
Sci Rep; 2017 Mar; 7():44242. PubMed ID: 28287131
[No Abstract] [Full Text] [Related]
17. [Nuclear medicine in oncotherapy].
Pávics L; Besenyi Z
Magy Onkol; 2015 Sep; 59(3):193-7. PubMed ID: 26339908
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide therapy revisited.
Hoefnagel CA
Eur J Nucl Med; 1991; 18(6):408-31. PubMed ID: 1879447
[TBL] [Abstract][Full Text] [Related]
19. Neutron-activated theranostic radionuclides for nuclear medicine.
Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
[TBL] [Abstract][Full Text] [Related]
20. Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
Druce MR; Lewington V; Grossman AB
Neuroendocrinology; 2010; 91(1):1-15. PubMed ID: 19590162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
